clinvestКачественная клиническая практикаKachestvennaya Klinicheskaya Praktika = Good Clinical Practice2588-05192618-8473ООО «Издательство ОКИclinvest-247Research ArticleБЕЗОПАСНОСТЬ ЛЕКАРСТВDRUG SAFETYВрачебные ошибки как причина осложнений лекарственной терапииЛепахинВ. К.clinvest@mail.ruАстаховаА. В.
кафедра общей и клинической фармакологии
clinvest@mail.ruОвчинниковаЕ. А.
кафедра общей и клинической фармакологии
clinvest@mail.ruОвчинниковаЛ. К.
кафедра общей и клинической фармакологии
clinvest@mail.ruРоссийский университет дружбы народов, МоскваRussian FederationФедеральное государственное учреждение «Экспертизы средств медицинского применения» МЗ РФ, г. МоскваRussian FederationФГУ «НЦ ЭСМП», г. МоскваRussian Federation200223062008017177Copyright © Лепахин В.К., Астахова А.В., Овчинникова Е.А., Овчинникова Л.К., 20182018Лепахин В.К., Астахова А.В., Овчинникова Е.А., Овчинникова Л.К.Лепахин В.К., Астахова А.В., Овчинникова Е.А., Овчинникова Л.К.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinvest.ru/jour/article/view/247врачебные ошибкиосложнения лекарственной терапиибезопасность лекарствReferencesQuality of Health Care in America Committee. The Institute of Medicine Report on Medical Errors: Misunderstanding Can Do Harm. Med. Gen. Med., September 19, 2000.Quality of Health Care in America Committee. The Institute of Medicine Report on Medical Errors: Misunderstanding Can Do Harm. Med. Gen. Med., September 19, 2000.Seeger J.D., Kong S.X., Schumock G. T. Characteristics associated with ability to prevent adverse-drug reactions in hospitalized patients. Pharmacotherapy, 1998, Nov-Dec, 18(6), 1284-1289.Seeger J.D., Kong S.X., Schumock G. T. Characteristics associated with ability to prevent adverse-drug reactions in hospitalized patients. Pharmacotherapy, 1998, Nov-Dec, 18(6), 1284-1289.Johnson J.A., Bootman J.L. Drug-related morbidity and mortality. A cost-of-illness model // J. Arch. Intern. Med., 1995, Oct. 9; 155 (18), 1949-1956.Johnson J.A., Bootman J.L. Drug-related morbidity and mortality. A cost-of-illness model // J. Arch. Intern. Med., 1995, Oct. 9; 155 (18), 1949-1956.Imbs J.L., Pouyanne P., Haramburu F. et al. Jatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers ol Pharmacuvigiaincc. Therapie 1999; 54 (1), 21-27.Imbs J.L., Pouyanne P., Haramburu F. et al. Jatrogenic medication: estimation of its prevalence in French public hospitals. Regional Centers ol Pharmacuvigiaincc. Therapie 1999; 54 (1), 21-27.Muehlberger N., Schneeweis S., Hasford J. ADRs Monitoringt Pharmacoepidemiology and drug safety, 1997, 6, Suppl.3, 71-77.Muehlberger N., Schneeweis S., Hasford J. ADRs Monitoringt Pharmacoepidemiology and drug safety, 1997, 6, Suppl.3, 71-77.Pirmohamed U., Breskenridge A.M., Kiteringham N.R. et al. Adverse drug reactions. BMJ, 1998, 316, 1295-1298.Pirmohamed U., Breskenridge A.M., Kiteringham N.R. et al. Adverse drug reactions. BMJ, 1998, 316, 1295-1298.UK Department of Health. An organization with a memory. 2000, December.UK Department of Health. An organization with a memory. 2000, December.Moore N.D., Lecaintre D., Noblet C. et al. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br. J. Clin. Pharmacol. 1998, 45 (3), 301-308.Moore N.D., Lecaintre D., Noblet C. et al. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br. J. Clin. Pharmacol. 1998, 45 (3), 301-308.Leape L., Brennan Т., Laird N. etal. The nature of adverse events in hospitalized patients: Results of the Harvard Medical Practice Study. New Engl. // J. Med., 1991, 324, 377-384.Leape L., Brennan Т., Laird N. etal. The nature of adverse events in hospitalized patients: Results of the Harvard Medical Practice Study. New Engl. // J. Med., 1991, 324, 377-384.Billings С. Incident reporting systems in medicine and experience with the aviation safety reporting systems. A Tale of Two Stories: (contrasting Views of Patient Safety. National Patient Safety Foundation, American Medical Association, Chicago Illinois, 1998.Billings С. Incident reporting systems in medicine and experience with the aviation safety reporting systems. A Tale of Two Stories: (contrasting Views of Patient Safety. National Patient Safety Foundation, American Medical Association, Chicago Illinois, 1998.Olsen P.M., Lorentzen H., Thomsen K., Fogtmann A. Medication errors in a pediatric department. Ugeskr. Laeger. 1997, Apr 14, 159 (16), 2392-2395.Olsen P.M., Lorentzen H., Thomsen K., Fogtmann A. Medication errors in a pediatric department. Ugeskr. Laeger. 1997, Apr 14, 159 (16), 2392-2395.Adverse Drug Events. Substantial problem but magnitude uncertain. US General Accounting Office. 2000, February, 1-12.Adverse Drug Events. Substantial problem but magnitude uncertain. US General Accounting Office. 2000, February, 1-12.Wllson R., Runciman W., Gibberd R. et al. The quality in Australian health care study. Med. J. Aust., 1995, 163, 458-471.Wllson R., Runciman W., Gibberd R. et al. The quality in Australian health care study. Med. J. Aust., 1995, 163, 458-471.Quality of Care Patient Safety. WHO, 2002, Resolution EB, 109, 16.Quality of Care Patient Safety. WHO, 2002, Resolution EB, 109, 16.Thomas P., Lombardi D. Closing the Loop - Implementing Quality Improvement Processes and Advances in Technology to Decrease Medication Errors. FASHP.Thomas P., Lombardi D. Closing the Loop - Implementing Quality Improvement Processes and Advances in Technology to Decrease Medication Errors. FASHP.Астахова A.B., Лепахин В.К. Проблемы безопасности лекарственных средств в России // Фармацевтический мир, 1997, №2, 10-12.Астахова A.B., Лепахин В.К. Проблемы безопасности лекарственных средств в России // Фармацевтический мир, 1997, №2, 10-12.V Российский национальный конгресс 'Человек и лекарство' // Безопасность лекарств. 1998, № 2, с. 14-15.V Российский национальный конгресс 'Человек и лекарство' // Безопасность лекарств. 1998, № 2, с. 14-15.Истратов С.Ю., Брайцева Е.В., Вартанян И.Р. Взаимодействие лекарственных средств // Новая аптека, 2000, № 9, с. 34-38.Истратов С.Ю., Брайцева Е.В., Вартанян И.Р. Взаимодействие лекарственных средств // Новая аптека, 2000, № 9, с. 34-38.Vincent С., Knox E. Clinical risk modification, quality, and patient safety: interrelationships, problems, and future potential. Best. Pract. Benchmarking. Healthc. 1997, Nov-Dec, 2(6), 221-226.Vincent С., Knox E. Clinical risk modification, quality, and patient safety: interrelationships, problems, and future potential. Best. Pract. Benchmarking. Healthc. 1997, Nov-Dec, 2(6), 221-226.Williams D., Kelly A., Feely J. Drug interactions avoided a useful indicator of good prescribing practice. Br. J. Clin. Pharmacol. 2000, Apr. 49(4), 369-372.Williams D., Kelly A., Feely J. Drug interactions avoided a useful indicator of good prescribing practice. Br. J. Clin. Pharmacol. 2000, Apr. 49(4), 369-372.
The authors declare that there are no conflicts of interest present.